BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 27345694)

  • 1. Chemotherapy-induced inflammation of seborrheic keratoses due to pemetrexed treatment.
    Matsudate Y; Murao K; Kubo Y
    J Dermatol; 2017 May; 44(5):602-603. PubMed ID: 27345694
    [No Abstract]   [Full Text] [Related]  

  • 2. Inflammation of seborrheic keratoses due to docetaxel treatment.
    Chu CY; Yang CH; Chiu HC
    Acta Derm Venereol; 2001; 81(4):316-7. PubMed ID: 11720193
    [No Abstract]   [Full Text] [Related]  

  • 3. Inflammation of seborrheic keratoses caused by cytarabine: a pseudo sign of Leser-Trelat.
    Patton T; Zirwas M; Nieland-Fisher N; Jukic D
    J Drugs Dermatol; 2004; 3(5):565-6. PubMed ID: 15552612
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epiphora following chemotherapy with pemetrexed in patients with advanced non-small cell lung cancer.
    Jung YD; Lee SB; Jung YW; Song JS; Woo IS
    Korean J Intern Med; 2017 Sep; 32(5):923-925. PubMed ID: 28298078
    [No Abstract]   [Full Text] [Related]  

  • 5. [Inflammation of multiple seborrheic keratoses induced by chemotherapy with gemcitabine].
    Siqueira CR; Miot HA
    An Bras Dermatol; 2009; 84(4):410-3. PubMed ID: 19851675
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inflamed Actinic Keratoses After Pemetrexed.
    Cameron MC; Suárez AL; Kris MG; Myskowski PL
    Skinmed; 2016; 14(6):473-474. PubMed ID: 28031141
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chemotherapy-induced inflammation in seborrheic keratoses mimicking disseminated herpes zoster.
    Williams JV; Helm KF; Long D
    J Am Acad Dermatol; 1999 Apr; 40(4):643-4. PubMed ID: 10188692
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pemetrexed-Induced Syncope.
    Chapman D; Taj A
    Am J Ther; 2019; 26(4):e548-e549. PubMed ID: 29927772
    [No Abstract]   [Full Text] [Related]  

  • 9. Lipodermatosclerosis secondary to pemetrexed use.
    Shuster M; Morley K; Logan J; Sequist LV; Shaw A; Fidias P; Kroshinsky D
    J Thorac Oncol; 2015 Mar; 10(3):e11-2. PubMed ID: 25695225
    [No Abstract]   [Full Text] [Related]  

  • 10. Chemotherapy-induced inflammatory seborrheic keratoses in a man with acute myeloid leukemia: a variant of Leser-Trélat sign?
    Lilly E; Granter SR; Haynes HA; Ibrahimi OA
    Cutis; 2012 Nov; 90(5):235-6. PubMed ID: 23270192
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of pemetrexed chemotherapy on the gut microbiota and intestinal inflammation of patient-lung-derived tumor xenograft (PDX) mouse models.
    Pensec C; Gillaizeau F; Guenot D; Bessard A; Carton T; Leuillet S; Campone M; Neunlist M; Blottière HM; Le Vacon F
    Sci Rep; 2020 Jun; 10(1):9094. PubMed ID: 32499509
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pemetrexed and interstitial lung disease.
    Adhikari B; Dongol RM; Baral D; Hewett Y; Shah BK
    Acta Oncol; 2016; 55(4):521-2. PubMed ID: 26366501
    [No Abstract]   [Full Text] [Related]  

  • 13. Generalized eczema craquelé (asteatotic dermatitis) associated with pemetrexed treatment.
    Chu CH; Chou CY; Lin FL
    J Eur Acad Dermatol Venereol; 2016 Oct; 30(10):e81-e83. PubMed ID: 26416293
    [No Abstract]   [Full Text] [Related]  

  • 14. Nivolumab induced inflammation of seborrheic keratoses: a novel cutaneous manifestation in a metastatic melanoma patient.
    Rambhia PH; Honda K; Arbesman J
    Melanoma Res; 2018 Oct; 28(5):475-477. PubMed ID: 29965880
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inflamed actinic keratoses associated with pemetrexed and carboplatin therapy.
    Lam J; Ellis SR; Sivamani RK
    Dermatol Online J; 2017 Oct; 23(10):. PubMed ID: 29469794
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pemetrexed-induced lower limb pseudocellulitis.
    Liau MM; Santosa A; Huang J; Tan LC
    Clin Exp Dermatol; 2017 Dec; 42(8):914-916. PubMed ID: 28815694
    [No Abstract]   [Full Text] [Related]  

  • 17. Prognostic factors in non-small cell lung cancer patients who are recommended to receive single-agent chemotherapy (docetaxel or pemetrexed) as a second- or third-line chemotherapy: in the era of oncogenic drivers and molecular-targeted agents.
    Shukuya T; Ko R; Mori K; Kato M; Yagishita S; Kanemaru R; Honma Y; Shibayama R; Koyama R; Shimada N; Takahashi K
    Cancer Chemother Pharmacol; 2015 Oct; 76(4):771-6. PubMed ID: 26259641
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transient eruptive seborrheic keratoses associated with erythrodermic psoriasis and erythrodermic drug eruption: report of two cases.
    Flugman SL; McClain SA; Clark RA
    J Am Acad Dermatol; 2001 Dec; 45(6 Suppl):S212-4. PubMed ID: 11712062
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chemotherapy-induced cardiomyopathy caused by Pemetrexed.
    Oyakawa T; Iida K; Kusuhara M; Kenmotsu H; Sugino T
    Invest New Drugs; 2018 Feb; 36(1):147-150. PubMed ID: 28660548
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Unusually prolonged pemetrexed cytotoxicity in a patient with a lung adenocarcinoma: a case report.
    Sakhri L; Pinsolle J; Moro-Sibilot D; Pluchart H
    J Med Case Rep; 2017 Sep; 11(1):262. PubMed ID: 28915906
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.